Disrupting the real-time medical imaging market, and accelerating innovation, with cloud Platform as a Service (PaaS)

Projektinformationen

Cydar PaaS

ID Finanzhilfevereinbarung: 674214

DOI 10.3030/674214

Abgeschlossenes Projekt

EK-Unterschriftsdatum 27 April 2015

Startdatum 1 Mai 2015

Enddatum 31 Oktober 2015

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

CYDAR LIMITED
United Kingdom

Ziel

Medical imaging science has progressed greatly in recent years with advances in cloud computing power, computer vision, machine learning and augmented reality. There is global political will to improve the efficiency of healthcare delivery through better exploitation of information technology. But there is surprisingly little translation of research output into clinical systems supporting real-time imaging.
Large hardware manufacturers currently dominate the software market for image-guided surgery. Their business model is based on high capital expenditure for installing large equipment that combines hardware and software. But this model means high costs and long lead times for changes, creating high barriers to innovation.
Cydar has identified an opportunity to disrupt this model by decoupling software innovation from the hardware. The concept is a dedicated cloud platform that hosts third-party applications, while handling image anonymisation, information security, governance and data storage. The core, tested technology involves a standard PC and web browser securely streaming the live imaging in the operating room to the cloud platform.
This business model is cloud Platform as a Service (PaaS), hosting applications for enterprises, healthcare organisations and academic institutions. Revenue streams include hosting fees and fees for access to the stored data for secondary use.
Crucially, end-user markets become widely accessible, costs are lowered, lead times slashed and the commercial risks of innovation reduced. The model is readily scalable for the global market. We expect it to accelerate the exploitation of medical digital data for the benefit of citizens, both as patients and as taxpayers.

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › surgery
• social sciences › economics and business › business and management › innovation management
• natural sciences › computer and information sciences › software › software applications › system software
• social sciences › economics and business › business and management › business models
• engineering and technology › medical engineering › diagnostic imaging

Programm/Programme

• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• ICT-37-2014-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument)

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2014-2015

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2014

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

CYDAR LIMITED

• Netto-EU-Beitrag: € 50 000,00
• Adresse: BULBECK MILL MILL LANE ; CB22 7QY BARRINGTON ; Vereinigtes Königreich
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  East of England › East Anglia › Cambridgeshire CC
• Region: East of England › East Anglia › Cambridgeshire CC
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00